Integrated Advisors Network
AZN icon

Integrated Advisors Network’s AstraZeneca AZN Stock Holding History

Integrated Advisors Network’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$370K Buy
2,289
+342
+18% +$57K 0.02% 521
2026
Q2 		$369K Sell
1,947
-373
-16% -$70.2K 0.02% 522
2026
Q1 		$458K Buy
2,320
+236
+11% +$45.5K 0.02% 478
2025
Q4 		$383K Sell
2,084
-633
-23% -$111K 0.02% 534
2025
Q3 		$417K Buy
2,717
+640
+31% +$96.9K 0.02% 548
2025
Q2 		$290K Buy
2,077
+131
+7% +$18.4K 0.01% 623
2025
Q1 		$286K Sell
1,946
-1,278
-40% -$185K 0.01% 592
2024
Q4 		$422K Sell
3,224
-18,581
-85% -$2.6M 0.02% 497
2024
Q3 		$3.4M Buy
21,805
+6,930
+47% +$1.12M 0.16% 157
2024
Q2 		$2.32M Buy
14,875
+11,502
+341% +$1.73M 0.12% 188
2024
Q1 		$457K Buy
3,373
+116
+4% +$15.4K 0.02% 484
2023
Q4 		$439K Buy
3,257
+171
+6% +$22.2K 0.02% 472
2023
Q3 		$418K Sell
3,086
-8
-0.3% -$1.09K 0.03% 470
2023
Q2 		$443K Sell
3,094
-136
-4% -$20K 0.03% 463
2023
Q1 		$448K Sell
3,230
-7,198
-69% -$968K 0.03% 462
2022
Q4 		$1.41M Buy
10,428
+435
+4% +$54.6K 0.09% 235
2022
Q3 		$1.1M Sell
9,993
-29,630
-75% -$3.76M 0.07% 254
2022
Q2 		$5.24M Buy
39,623
+998
+3% +$131K 0.34% 75
2022
Q1 		$5.12M Buy
38,625
+903
+2% +$108K 0.3% 77
2021
Q4 		$4.4M Buy
37,722
+329
+0.9% +$38.7K 0.26% 103
2021
Q3 		$4.49M Buy
37,393
+29,513
+375% +$3.44M 0.3% 85
2021
Q2 		$944K Sell
7,880
-1,698
-18% -$186K 0.07% 231
2021
Q1 		$952K Sell
9,578
-14,719
-61% -$1.48M 0.09% 215
2020
Q4 		$2.43M Sell
24,297
-4,562
-16% -$483K 0.27% 108
2020
Q3 		$3.16M Buy
+28,859
New +$3.21M 0.4% 69

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Integrated Advisors Network's AZN Position: Q3 2026 in Review

Integrated Advisors Network increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $57K and bringing the position to 2,289 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #521.

Integrated Advisors Network first reported a position in AZN in Q3 2020 and has held it in 25 quarters since. The position peaked at $5.24M in Q2 2022. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Integrated Advisors Network held 2,289 shares of AstraZeneca worth $370K as of Q3 2026.
  • Integrated Advisors Network bought 342 AstraZeneca shares in Q3 2026, an estimated $57K.
  • AstraZeneca made up 0.02% of Integrated Advisors Network's portfolio in Q3 2026, its #521 holding.
  • Integrated Advisors Network first reported a position in AstraZeneca in Q3 2020 and has held it in 25 quarters since.
  • Integrated Advisors Network's AstraZeneca position peaked at $5.24M in Q2 2022.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.